Skip to content

Clinical trials

Myeloproliferative Disorders trials in the United Kingdom with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Unknown status Country / region: United Kingdom Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC1
St. Bartholomew's Hospital1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders3
Congenital Abnormalities2
Leukemia2
Leukemia, Myeloid, Acute2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative2
Leukemia, Myelomonocytic, Chronic2
Myelodysplastic Syndromes2
Myelodysplastic-Myeloproliferative Diseases2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia, Refractory1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.